Analytes related to erythrocyte metabolism are reliable biomarkers for preanalytical error due to delayed plasma processing in metabolomics studies.

BACKGROUND Delaying plasma separation after phlebotomy (processing delay) can cause perturbations of numerous small molecule analytes. This poses a major challenge to the clinical application of metabolomics analyses. In this study, we further define the analyte changes that occur during processing delays and generate a model for the post hoc detection of this preanalytical error. METHODS Using an untargeted metabolomics platform we analyzed EDTA-preserved plasma specimens harvested after processing delays lasting from minutes to days. Identified biomarkers were tested on (i) a test-set of samples exposed to either minimal (n=28) or long delays (n=40) and (ii) samples collected in a clinical setting for metabolomics analysis (n=141). RESULTS A total of 149 of 803 plasma analytes changed significantly during processing delays lasting 0-20h. Biomarkers related to erythrocyte metabolism, e.g., 5-oxoproline, lactate, and an ornithine/arginine ratio, were the strongest predictors of plasma separation delays, providing 100% diagnostic accuracy in the test set. Together these biomarkers could accurately predict processing delays >2h in a pilot study and we found evidence of sample mishandling in 4 of 141 clinically derived specimens. CONCLUSIONS Our study highlights the widespread effects of processing delays and proposes that erythrocyte metabolism creates a reproducible signal that can identify mishandled specimens in metabolomics studies.

[1]  Mario Plebani,et al.  Quality indicators to detect pre-analytical errors in laboratory testing. , 2012, The Clinical biochemist. Reviews.

[2]  J. Schafer.  Multiple imputation: a primer , 1999, Statistical methods in medical research.

[3]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[4]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[5]  Simone Wahl,et al.  Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples , 2014, PloS one.

[6]  Gabi Kastenmüller,et al.  Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples , 2015, PloS one.

[7]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[8]  Nir Giladi,et al.  [Mitochondrial myopathy]. , 1990, Harefuah.

[9]  Rainer Lehmann,et al.  Effects of pre-analytical processes on blood samples used in metabolomics studies , 2015, Analytical and Bioanalytical Chemistry.

[10]  John W Seaman,et al.  Multiple imputation techniques in small sample clinical trials , 2006, Statistics in medicine.

[11]  S. Dimauro,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome , 1984, Annals of neurology.

[12]  A. Meister,et al.  Formation of 5-oxoproline from glutathione in erythrocytes by the gamma-glutamyltranspeptidase-cyclotransferase pathway. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Collins,et al.  Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. , 2003, International journal of epidemiology.

[14]  M. Milburn,et al.  Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.

[15]  Peter Kraft,et al.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. , 2013, Clinical chemistry.

[16]  Douglas B. Kell,et al.  Molecular phenotyping of a UK population: defining the human serum metabolome , 2014, Metabolomics.

[17]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[18]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[19]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[20]  Hui Zhang,et al.  Application of near-infrared spectroscopy combined with multivariate analysis in monitoring of crude heparin purification process. , 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[21]  David Wong,et al.  Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. , 2013, Clinical biochemistry.

[22]  S. Cederbaum,et al.  Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. , 1985, American journal of human genetics.

[23]  John H Kalivas,et al.  Assessment of Pareto Calibration, Stability, and Wavelength Selection , 2003, Applied spectroscopy.

[24]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[25]  Paul Geladi,et al.  Principal Component Analysis , 1987, Comprehensive Chemometrics.

[26]  C. Högman,et al.  Storage parameters affecting red blood cell survival and function after transfusion. , 1999, Transfusion medicine reviews.

[27]  Adam D. Kennedy,et al.  Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.

[28]  Fabian J Theis,et al.  The dynamic range of the human metabolome revealed by challenges , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Corey D. DeHaven,et al.  High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High- Throughput Profiling Metabolomics , 2014 .

[30]  N. Deutz,et al.  Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. , 2007, The American journal of clinical nutrition.

[31]  David E Bruns,et al.  Stabilization of glucose in blood samples: why it matters. , 2009, Clinical chemistry.

[32]  D. Häussinger,et al.  Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature , 2015, Amino Acids.

[33]  D. Morrow,et al.  Preanalytical considerations in the design of clinical trials and epidemiological studies. , 2015, Clinical chemistry.

[34]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[35]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[36]  Kenneth E Blick,et al.  Stability studies of twenty-four analytes in human plasma and serum. , 2002, Clinical chemistry.

[37]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[38]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.